Zobrazeno 1 - 10
of 383
pro vyhledávání: '"Pär Stattin"'
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-9 (2022)
BMC Urology
BMC Urology
Background: Epidemiological data on anticoagulation for venous thromboembolism (VTE) in prostate cancer are sparse. We aimed to investigate associations between anticoagulation duration and risks of VTE recurrence after treatment cessation and major
Autor:
Johan Syrjä, Mats Lambe, David Robinson, Irma Fredriksson, Pär Stattin, Rolf Gedeborg, Malin Sund, Hans Garmo, Anna Plym, Lars Holmberg
Publikováno v:
Epidemiology. 32:607-615
Background The ability to account for comorbidity when estimating survival in a population diagnosed with cancer could be improved by using a drug comorbidity index based on filled drug prescriptions. Methods We created a drug comorbidity index from
Autor:
Suzanne Kilany, Ingela Franck Lissbrant, Karin Fagerlund, Johanna Svensson, Pär Stattin, Oskar Gauffin, Marie Hjälm-Eriksson
Publikováno v:
Scandinavian Journal of Urology. 55:1-8
To investigate time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer in Sweden, and the associated health economic impact.Registry study (NCT03619980) of the Prostate Cancer data Base Sweden with
Publikováno v:
Journal of Urology. 204:714-719
5α-Reductase inhibitors reduced the risk of prostate cancer in 25% in 2 randomized trials but increased the risk of Gleason 8-10 at biopsy. One explanation is that 5α-reductase inhibitors induce morphological changes in prostate cancer cells simila
Autor:
Daniel Sjöberg, Robert Johansson, Göran Hallmans, Emily Vertosick, Pär Stattin, Andrew J. Vickers, Hans Lilja, Christel Häggström
Publikováno v:
J Urol
PURPOSE: A pre-specified statistical model based on four kallikrein markers in blood, commercially available as the 4Kscore, has been shown to accurately detect high grade (>Grade Group 2) prostate cancer in men with moderately elevated PSA. We aimed
Publikováno v:
BJU International. 125:679-685
Objective To investigate whether post-transplantation immunosuppression negatively affects prostate cancer outcomes in male kidney transplant recipients. Patients and methods We used the Swedish Renal Register and the National Prostate Cancer Registe
Autor:
Renata Zelic, Pär Stattin, Hans Garmo, Andreas Pettersson, Lorenzo Richiardi, Olof Akre, Daniela Zugna
Publikováno v:
Transl Androl Urol
Background Numerous pretreatment risk classification tools are available for prostate cancer. Which tool is best in predicting prostate cancer death is unclear. Objective To systematically compare the prognostic performance of the most commonly used
Autor:
Ingela Franck Lissbrant, Marcus Westerberg, Hans Garmo, Jan-Erik Damber, Pär Stattin, David Robinson
Publikováno v:
Acta Oncologica. 59:106-111
Background: There have been large changes in the pattern of detection, work-up and treatment of men with prostate cancer during the last two decades. Therefore, we aimed to investigate temporal changes in survival in men with metastatic prostate canc
Autor:
Ove Gustafsson, Maria Hermann, Pär Stattin, Johan Styrke, Asmatullah Katawazai, Gabriel Sandblom, Hanna Vikman
Publikováno v:
British Journal of Surgery. 108
Aim To investigate whether androgen deprivation therapy (ADT) for prostate cancer increases the risk for inguinal hernia. Material and Methods A population-based nested case-control study based on data from the Prostate Cancer Database Sweden. The co
Autor:
Richard Shore, Pär Stattin, Weimin Ye, Jingru Yu, Jesper Lagergren, Mats Lindblad, Olof Akre, Martin Rutegård
Publikováno v:
Diseases of the Esophagus. 34
There is an unexplained male predominance in the incidence of esophageal (EAC) and non-cardia gastric adenocarcinoma (GAC) which cannot be explained by known risk factors. Differences in the exposures to sex hormones may play a part in the observed s